Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers (NATURE)
Sponsor: LivaNova
A observational or N/A phase clinical study on Patients Implanted With a Pacemaker, this trial is completed. The trial is conducted by LivaNova and has accumulated 8 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Dec 2017 [monthly]
Completed NA
First recorded
Jun 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- LivaNova
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Agen, France , Albi, France , Almada, Portugal , Alès, France , Annaberg, Germany , Annecy, France , Aressy, France , Auch, France , Bayonne, France , Beauvais, France and 107 more locations